Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Insulin efsitora alfa by Eli Lilly and Co for Type 2 Diabetes: Likelihood of Approval
Insulin efsitora alfa is under clinical development by Eli Lilly and Co and currently in Phase III for Type 2...
Insulin efsitora alfa by Eli Lilly and Co for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Insulin efsitora alfa is under clinical development by Eli Lilly and Co and currently in Phase III for Type 1...
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co's Insulin efsitora alfa?
Insulin efsitora alfa is a fusion protein commercialized by Eli Lilly and Co, with a leading Phase III program in...
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co's Insulin efsitora alfa?
Insulin efsitora alfa is a fusion protein commercialized by Eli Lilly and Co, with a leading Phase III program in...